Outgoing FDA Commissioner Proposes Expedited Steps for Approval of CBD
![Cannabis Law (leaf)](/sites/default/files/styles/fullscreen_4x3_767x575_1x/public/2024-07/Cannabis%20Law%20%28Tertiary%29%20%281%29.jpg?itok=QI0GLGft)
On July 31, Dr. Scott Gottlieb, the outgoing FDA commissioner, published an editorial in which he proposed how the FDA could expedite approval of food and beverage products that contain cannabidiol (CBD).
In this update, we review Dr. Gottlieb's proposal which highlights areas of concern for business involved in the CBD industry, such as labeling and deceptive marketing.
Print and share
Authors
Explore more in
Consumer Protection Review
Consumer Protection Review helps businesses that market and sell to consumers navigate federal and state legal issues related to advertising, privacy, promotions, products liability, government investigations, unfair competition, class actions and general consumer protection. Subscribe 🡢